0001217234-23-000160.txt : 20230713 0001217234-23-000160.hdr.sgml : 20230713 20230713205646 ACCESSION NUMBER: 0001217234-23-000160 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230713 FILED AS OF DATE: 20230713 DATE AS OF CHANGE: 20230713 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Seeto Reginald CENTRAL INDEX KEY: 0001688485 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36536 FILM NUMBER: 231087830 MAIL ADDRESS: STREET 1: C/O ARDELYX, INC. STREET 2: 34175 ARDENWOOD BLVD, SUITE 200 CITY: FREMONT STATE: CA ZIP: 94555 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CareDx, Inc. CENTRAL INDEX KEY: 0001217234 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 943316839 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 8000 MARINA BLVD STREET 2: 4TH FLOOR CITY: BRISBANE STATE: CA ZIP: 94005 BUSINESS PHONE: 415-287-2300 MAIL ADDRESS: STREET 1: 8000 MARINA BLVD STREET 2: 4TH FLOOR CITY: BRISBANE STATE: CA ZIP: 94005 FORMER COMPANY: FORMER CONFORMED NAME: XDx, Inc. DATE OF NAME CHANGE: 20071010 FORMER COMPANY: FORMER CONFORMED NAME: EXPRESSION DIAGNOSTICS INC DATE OF NAME CHANGE: 20030203 4 1 wf-form4_168929619308128.xml FORM 4 X0407 4 2023-07-13 0 0001217234 CareDx, Inc. CDNA 0001688485 Seeto Reginald C/O CAREDX, INC. 8000 MARINA BOULEVARD, 4TH FLOOR BRISBANE CA 94005 1 1 0 0 See Remarks 0 Common Stock 2023-07-13 4 S 0 5260 10.3341 D 488870 D This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2022. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.11 to $10.71, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price. Includes 815 shares acquired pursuant to the Issuer's 2014 Employee Stock Purchase Plan. President and Chief Executive Officer. /s/ Reginald Seeto 2023-07-13